Trial intelligence / Profile preview

Esketamine plus propofol for painless gastrointestinal endoscopy

ChiCTR2000039750Phase 4Recruiting

Sponsor
First Affiliated Hospital of Jinan University
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of esketamine and propofol in None (4 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoint: Propofol consumption per minute. Started Nov 2020; status: recruiting.

02

Drugs

esketaminepropofol

Beyond the preview

Go deeper on ChiCTR2000039750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000039750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call